Abstract: A retractable awning having a roller, a flexible canopy having one end secured to the roller and rollable onto the roller, and a motor operable to rotate the roller to roll the flexible canopy onto or off the roller. Top and bottom mounting arms extend from a support arm for the roller, with the bottom arm being articulated, and with an extensible strut pivotally connected to and extending between each top and bottom mounting arm.

Abstract: A retractable awning having a roller, a flexible canopy having one end secured to the roller and rollable onto the roller, and a motor operable to rotate the roller to roll the flexible canopy onto or off the roller. Top and bottom mounting arms extend from a support arm for the roller, with the bottom arm being articulated, and with an extensible strut pivotally connected to and extending between each top and bottom mounting arm.

Abstract: A method for assigning a first motor vehicle to a second motor vehicle by exchanging electromagnetic signals. The electromagnetic signals are transmitted from the first motor vehicle in a predetermined temporal signal pattern and received by the second motor vehicle, where they are compared as to whether the received electromagnetic signals correspond to a signal pattern stored in the second motor vehicle. The first motor vehicle then is assigned as a function of the comparison. This method is particularly suited to assigning trailers to a towing vehicle.

Abstract: New benzimidazole derivatives are described, their production and their use for the production of pharmaceutical agents for treatment and prevention of diseases that are associated with a microglia activation and T-cell-mediated immunological diseases, as well as pharmaceutical preparations that contain the new benzimidazole derivatives.

Abstract: A method for assigning a first motor vehicle to a second motor vehicle by exchanging electromagnetic signals. The electromagnetic signals are transmitted from the first motor vehicle in a predetermined temporal signal pattern and received by the second motor vehicle, where they are compared as to whether the received electromagnetic signals correspond to a signal pattern stored in the second motor vehicle. The first motor vehicle then is assigned as a function of the comparison. This method is particularly suited to assigning trailers to a towing vehicle.

Abstract: The invention relates to novel benzimidazole derivatives with general formula I, whereby radicals R1, R2, R3, A, B, Y and Z have the meanings that are indicated in the description and the claims, the use of these compounds for the production of a pharmaceutical agent for treatment and prevention of diseases associated with microglia activation as well as pharmaceutical preparations that contain these compounds

Abstract: Thiazolidinones of general formula I in which Q, A, B, X, R1 and R2 have the meanings that are indicated in the description, as well as those of general formula IA in which Q, A, B, X, R1 and R2a have the meanings that are indicated in the description, their production and use as inhibitors of the polo-like kinase (PLK) for treating various diseases as well as intermediate products for the production of thiazolidinones are described.

Abstract: The invention relates to an electronic component comprising at least two connection elements (2, 7, 8), each provided with at least one contact surface (13.1, 13.2, 13.3, 9, 10) which is used to fix the electronic component (1) to a surface of a printed circuit board. An at least partially plane cooling surface is formed on the first connection element (2), for placing on a cooling body that is oriented in the direction of the side of the electronic component (1) opposing the printed circuit board. The first connection element (2) has at least one raised area (3.1, 3.2, 3.3) on the side thereof facing the printed circuit board, on which the contact surface (13.1, 13.2, 13.3) of the first connection element (2) is formed. Said first connection element (2) also has at least one recessed area (4, 4?) in which the at least one other connection element (7, 7?; 8, 8?) is arranged.

Abstract: The invention describes the use of microglia inhibitors for the production of pharmaceutical agents that inhibit immune reactions that are mediated by monocytes, macrophages and T cells, and their use for treating T-cell-mediated immunological diseases and non-T-cell-mediated inflammation reactions.

Abstract: New benzimidazole derivatives are described, their production and their use for the production of pharmaceutical agents for treatment and prevention of diseases that are associated with a microglia activation and T-cell-mediated immunological diseases, as well as pharmaceutical preparations that contain the new benzimidazole derivatives.

Abstract: New benzimidazole derivatives are described, their production and their use for the production of pharmaceutical agents for treatment and prevention of diseases that are associated with a microglia activation and T-cell-mediated immunological diseases, as well as pharmaceutical preparations that contain the new benzimidazole derivatives.

Abstract: The invention relates to novel benzimidazole derivatives with general formula I, whereby radicals R1, R2, R3, A, B, Y and Z have the meanings that are indicated in the description and the claims, the use of these compounds for the production of a pharmaceutical agent for treatment and prevention of diseases associated with microglia activation as well as pharmaceutical preparations that contain these compounds.

Abstract: The invention relates to novel benzimidazole derivatives with general formula I, whereby radicals R1, R2, R3, A, B, Y and Z have the meanings that are indicated in the description and the claims, the use of these compounds for the production of a pharmaceutical agent for treatment and prevention of diseases associated with microglia activation as well as pharmaceutical preparations that contain these compounds

Abstract: The invention relates to novel benzimidazole derivatives with general formula I, whereby radicals R1, R2, R3, A, B and Y have the meanings that are indicated in the description and the claims, the use of these compounds for the production of a pharmaceutical agent for treating and for preventing diseases that are associated with microglia activation, as well as pharmaceutical preparations that contain these compounds.

Abstract: The invention describes the use of microglia inhibitors for the production of pharmaceutical agents that inhibit immune reactions that are mediated by monocytes, macrophages and T cells, and their use for treating T-cell-mediated immunological diseases and non-T-cell-mediated inflammation reactions.

Abstract: New benzimidazole derivatives are described, their production and their use for the production of pharmaceutical agents for treatment and prevention of diseases that are associated with a microglia activation and T-cell-mediated immunological diseases, as well as pharmaceutical preparations that contain the new benzimidazole derivatives.

Abstract: The invention relates to novel benzimidazole derivatives with general formula I, whereby radicals R1, R2, R3, A, B, Y and Z have the meanings that are indicated in the description and the claims, the use of these compounds for the production of a pharmaceutical agent for treatment and prevention of diseases associated with microglia activation as well as pharmaceutical preparations that contain these compounds.

Abstract: The invention relates to novel benzimidazole derivatives with general formula I, whereby radicals R1, R2, R3, A, B and Y have the meanings that are indicated in the description and the claims, the use of these compounds for the production of a pharmaceutical agent for treating and for preventing diseases that are associated with microglia activation, as well as pharmaceutical preparations that contain these compounds.

Abstract: The invention relates to the compounds of Formula I as well as the process for their production and their use as pharmaceutical agents.

Abstract: Quinoxalinedione derivatives ##STR1## as well as their production and use in pharmaceutical agents are described.